Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
See Latest ArticlesEtanercept in the longterm treatment of patients with ankylosing spondylitis
Journal of Rheumatology, 06/11/09
Dijkmans B et al. – In the two year study period, etanercept was clinically effective and well tolerated, with no unexpected safety findings, in pts with ankylosing spondylitis (AS).
Methods- An evaluation of the 2-yr efficacy and safety of etanercept in pts with AS
- A 96-wk open-label extension study, which followed a 12-wk double-blind placebo-controlled trial
- Pts were treated with etanercept 25 mg x2/wk
- In all, 81 pts were enrolled (96% of the participants from the double-blind study)
- Key efficacy measures: improvement using-
- Assessment in Ankylosing Spondylitis 20% (ASAS20) criteria
- Bath Ankylosing Spondylitis Functional Index (BASFI), and
- Bath Ankylosing Spondylitis Disease Activity Index (BASDAI)
- Radiographic progression was evaluated using the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) method
- Percentage of responders, by ASAS20 criteria, remained relatively constant in pts who received etanercept during the 12-wk double-blind study
- More pts from the placebo group became responders after being switched to etanercept
- A similar trend was also observed using the ASAS40 and ASAS5/6 criteria, the BASFI, and the BASDAI
- Most pts had no change from baseline in mSASSS values
- Etanercept was well tolerated:
- Most frequent AEs were injection site reactions, and headache
- Most frequent infections were upper respiratory tract infections and flu syndrome
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Treatment of polymyalgia rheumatica
Archives of Internal Medicine, 11/10/09
Osteonecrosis of the jaw correlated to bisphosphonate therapy in non-oncologic patients: Clinicopathological features of 24 patients
Journal of Rheumatology, 11/09/09
Osteoarthritis: A review of treatment options
Geriatrics, 10/21/09
Today in Spondylarthropathies...keeping you current
Receive free subspecialty "5-minute updates" via email
Erythrocyte sedimentation rate, CRP level, and serum amyloid a protein for patient selection and monitoring of anti-tumor necrosis factor treatment in ankylosing spondylitis
Arthritis Care and Research , 11/02/09
Agreement between quantiferon-TB gold test and tuberculin skin test in the identification of latent tuberculosis infection in patients with rheumatoid arthritis and ankylosing spondylitis
Journal of Rheumatology, 11/18/09
Recreational Exercise in Rheumatic Diseases
International Journal of Sports Medicine, 10/30/09
Sponsor
Article Search
Sponsor